42 related articles for article (PubMed ID: 34034913)
21. Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study.
Chu J; Cai H; Cai J; Bian X; Cheng Y; Guan X; Chen X; Jiang H; Zhai X; Fang Y; Zhang L; Tian X; Zhou F; Wang Y; Wang L; Li H; Kwan Alex LW; Yang M; Yang H; Zhan A; Wang N; Hu S
Front Oncol; 2022; 12():1062065. PubMed ID: 36624786
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.
Sun K; Wang J; Chen WM; Xu N; Long LY; Wang X; Jiang H; Jiang Q; Huang XJ; Qin YZ
Biomol Biomed; 2023 Mar; 23(2):298-309. PubMed ID: 36124444
[TBL] [Abstract][Full Text] [Related]
23.
Wang X; Niu F; Ren J; He P
Quant Imaging Med Surg; 2022 Jul; 12(7):4002-4004. PubMed ID: 35782267
[No Abstract] [Full Text] [Related]
24. ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
Goswami S; Chiang CL; Zapolnik K; Nunes J; Ventura A; Mo X; Xie Z; Lee LJ; Baskar S; Rader C; Byrd JC; Phelps M; Bhatnagar B; Muthusamy N
Leuk Res; 2022 Jul; 118():106872. PubMed ID: 35640397
[No Abstract] [Full Text] [Related]
25. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer.
Yu X; Li Z; Bai R; Tang F
Bioengineered; 2022 May; 13(5):12516-12531. PubMed ID: 35587604
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
[TBL] [Abstract][Full Text] [Related]
28. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
[TBL] [Abstract][Full Text] [Related]
32. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
33. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Jędraszek K; Malczewska M; Parysek-Wójcik K; Lejman M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328487
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
